Search by Drug Name or NDC
NDC 70257-0126-51 VARIZIG 125 [iU]/1.2mL Details
VARIZIG 125 [iU]/1.2mL
VARIZIG is a INTRAMUSCULAR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Saol Therapeutics. The primary component is HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN.
Product Information
| NDC | 70257-0126 |
|---|---|
| Product ID | 70257-126_acfa976e-7b2c-4238-be60-dc597273c52a |
| Associated GPIs | 19100070002015 |
| GCN Sequence Number | 074130 |
| GCN Sequence Number Description | varicella-zoster Ig/maltose VIAL 125/1.2 ML INTRAMUSC |
| HIC3 | W7K |
| HIC3 Description | ANTISERA |
| GCN | 38686 |
| HICL Sequence Number | 042055 |
| HICL Sequence Number Description | VARICELLA-ZOSTER IMMUNE GLOBULIN/MALTOSE |
| Brand/Generic | Brand |
| Proprietary Name | VARIZIG |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 125 |
| Active Ingredient Units | [iU]/1.2mL |
| Substance Name | HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN |
| Labeler Name | Saol Therapeutics |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125430 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70257-0126-51 (70257012651)
| NDC Package Code | 70257-126-51 |
|---|---|
| Billing NDC | 70257012651 |
| Package | 1 VIAL, GLASS in 1 CARTON (70257-126-51) / 1.2 mL in 1 VIAL, GLASS (70257-126-11) |
| Marketing Start Date | 2019-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |